BBLG
$1.24
Market ClosedAs of Mar 17, 8:00 PM UTC
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States.
Historical Price
Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.24
Potential Upside
5%
Whystock Fair Value$1.30
Price
UndervaluedFair ValueOvervalued
Fundamentals
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.23M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.42
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-70.17%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
12.77
Recent News
BC-Most Active Stocks
td class="col-issue">Next Technology Holding Inc.
Traders Digest Fed's Preferred Inflation Gauge as US Equity Futures Gain Pre-Bell
US equity futures were up ahead of Friday's opening bell as traders digested the Federal Reserve's p